Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Pediatric Medicines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.7% during the forecast period.
This report presents the market size and development trends by detailing the Pediatric Medicines market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Pediatric Medicines market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Pediatric Medicines industry and will help you to build a panoramic view of the industrial development.
Pediatric Medicines Market, By Type:
Enteral
Parenteral
Topical
Pediatric Medicines Market, By Application:
Hospital
Clinic
Family
Some of the leading players are as follows:
F. Hoffman-La Roche
Glenmark
Heron Therapeutics
GSK
Helsinn Healthcare
Novartis
F Hoffman-La Roche
Sanofi
Abbott
Bristol-Myers Squibb
Ipca Laboratories
Cipla
Eisai Pharmaceuticals
Eli Lilly
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Pediatric Medicines Market: Technology Type Analysis
-
4.1 Pediatric Medicines Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Pediatric Medicines Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Enteral
4.3.2 Parenteral
4.3.3 Topical
5 Pediatric Medicines Market: Product Analysis
-
5.1 Pediatric Medicines Product Market Share Analysis, 2018 & 2026
-
5.2 Pediatric Medicines Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Pediatric Medicines Market: Application Analysis
-
6.1 Pediatric Medicines Application Market Share Analysis, 2018 & 2026
-
6.2 Pediatric Medicines Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Hospital
6.3.2 Clinic
6.3.3 Family
7 Pediatric Medicines Market: Regional Analysis
-
7.1 Pediatric Medicines Regional Market Share Analysis, 2018 & 2026
-
7.2 Pediatric Medicines Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 F. Hoffman-La Roche
9.1.1 F. Hoffman-La Roche Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Glenmark
9.2.1 Glenmark Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Heron Therapeutics
9.3.1 Heron Therapeutics Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 GSK
9.4.1 GSK Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Helsinn Healthcare
9.5.1 Helsinn Healthcare Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Novartis
9.6.1 Novartis Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 F Hoffman-La Roche
9.7.1 F Hoffman-La Roche Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Sanofi
9.8.1 Sanofi Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Abbott
9.9.1 Abbott Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Bristol-Myers Squibb
9.10.1 Bristol-Myers Squibb Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Ipca Laboratories
9.11.1 Ipca Laboratories Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Cipla
9.12.1 Cipla Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Eisai Pharmaceuticals
9.13.1 Eisai Pharmaceuticals Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Eli Lilly
9.14.1 Eli Lilly Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
The List of Tables and Figures (Totals 100 Figures and 129 Tables)
Figure Enteral Pediatric Medicines market, 2015 - 2026 (USD Million)
Figure Parenteral Pediatric Medicines market, 2015 - 2026 (USD Million)
Figure Topical Pediatric Medicines market, 2015 - 2026 (USD Million)
Figure Hospital market, 2015 - 2026 (USD Million)
Figure Clinic market, 2015 - 2026 (USD Million)
Figure Family market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Pediatric Medicines market, by country, 2015 - 2026 (USD Million)
-
Table North America Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table North America Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table North America Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table Canada Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table Canada Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Europe Pediatric Medicines market, by country, 2015 - 2026 (USD Million)
-
Table Europe Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table Europe Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table Europe Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table Germany Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table Germany Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table France Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table France Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table Italy Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table Italy Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table Spain Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table Spain Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pediatric Medicines market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table China Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table China Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table Japan Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table Japan Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table India Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table India Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Pediatric Medicines market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table MEA Pediatric Medicines market, by country, 2015 - 2026 (USD Million)
-
Table MEA Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table MEA Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table MEA Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Pediatric Medicines market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Pediatric Medicines market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Pediatric Medicines market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table F. Hoffman-La Roche Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Glenmark Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Heron Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GSK Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Helsinn Healthcare Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table F Hoffman-La Roche Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Abbott Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ipca Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cipla Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eisai Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
